我要投票 朗迪Reneed在补钙行业中的票数:148
· 外 推 电 报 ·
2025-01-22 17:59:13 星期三

【朗迪Reneed是哪个国家的品牌?】

朗迪Reneed是什么牌子?「朗迪Reneed」是 北京振东康远制药有限公司 旗下著名品牌。该品牌发源于北京市,由创始人李昆在2003-11-07期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

钙营养补充剂品牌,主打维生素矿物质钙补充剂类药物,集研发、生产、销售于一体的集团化现代综合制药企业


北京振东康远制药有限公司始建于2003年10月,是国内较大的具有自主品牌的维生素矿物质钙补充剂类药物生产企业,是一家集研发、生产、销售于一体的集团化现代综合制药公司,是中国补钙药物的佼佼者和先锋。公司产品遍布全国,公司“朗迪”牌碳酸钙D3片(II)和碳酸钙D3颗粒已成为中国钙补充剂类药品市场的主流。公司2015年与上市公司振东集团山西振东制药股份有限公司强强联合,完成重大重组,实现了跨跃式发展。

公司于2009年进入中国钙制剂市场,旗下现有7家直属或控股的制药公司、2家直属药物研发公司及多家医药贸易公司,在30多个城市设立了办事机构,有数千家合作伙伴,累计总投资超过10亿元,全国有数千名员工为康远工作。

公司位于北京市昌平区西部约15公里的北京市昌平区流村工业园内,隶属中关村科技园昌平园。该厂区自2012年开始建造,总投资近亿元,按照新版欧盟GMP标准及中国GMP标准进行规划、设计和建设施工,配有国际前沿的制粒、干燥、混合、压片、包装等片剂、硬胶囊剂、颗粒剂生产线及软胶囊剂生产线,该项目已于2014年通过了BFDA组织的GMP认证,并获得片剂、硬胶囊剂、颗粒剂、软胶囊剂GMP证书。项目年生产能力近百亿片(粒、袋)。该项目的建成使康远制药一跃成为国内维生素矿物质钙补充剂类药物较大生产企业。

公司发展过程中始终以“构建国人健康骨骼”为已任,以“树民族工业品牌,为中国制药争光”为使命,为中国钙制剂的发展做出了较大的贡献,大大改善了亿万国人的生活质量。康远人负有共同的使命,遵循一致的价值观,始终秉承“济世安康、立勋鸿远”宗旨来服务社会、回报社会。目前公司年营业收入达数十亿元,年上缴税金数亿元。随着公司高速发展和对未来中国经济和全球钙制剂市场发展前景充分信心,北京振东康远制药正不断加快创新、运筹帷幄、酝酿百年规划,未来的康远终将成为一家拥有精良技术和设备、管理成熟的世界制药公司。


英文翻译:Beijing Zhendong Kangyuan Pharmaceutical Co., Ltd., a brand of calcium supplements, is a group modern comprehensive pharmaceutical enterprise integrating R & D, production and sales. It was founded in October 2003. It is a large domestic manufacturer of vitamin and mineral calcium supplements with its own brand, integrating R & D, production and sales Group modern comprehensive pharmaceutical company is the leader and pioneer of calcium supplements in China. The company's products are all over the country, and its "landi" brand calcium carbonate D3 tablets (II) and calcium carbonate D3 particles have become the mainstream of China's calcium supplements market. In 2015, the company and the listed company Zhendong Group Shanxi Zhendong Pharmaceutical Co., Ltd. jointly completed major restructuring and achieved a leap forward development. In 2009, the company entered the calcium preparation market in China. At present, it has 7 pharmaceutical companies directly under or controlled by the company, 2 pharmaceutical research and development companies directly under the company and many pharmaceutical trading companies. It has set up offices in more than 30 cities, thousands of partners, with a total investment of more than 1 billion yuan, and thousands of employees working for Kangyuan. The company is located in Liucun Industrial Park, Changping District, Beijing, about 15km away from the west of Changping District, Beijing. The plant has been constructed since 2012, with a total investment of nearly 100 million yuan. It is planned, designed and constructed in accordance with the new version of EU GMP standard and China GMP standard. It is equipped with internationally cutting-edge tablet, hard capsule, granule production line and soft capsule production line. The project has passed the GMP certification organized by bfda in 2014, and has obtained tablet GMP certificate of hard capsule, granule and soft capsule. The annual production capacity of the project is nearly 10 billion pieces (grain and bag). With the completion of the project, Kangyuan pharmaceutical has become a large domestic manufacturer of vitamin, mineral and calcium supplements. In the development process of the company, we always take "building healthy skeleton of Chinese people" as our responsibility, take "building national industrial brand, winning honor for Chinese pharmaceutical" as our mission, and have made great contribution to the development of Chinese calcium preparation, greatly improving the quality of life of hundreds of millions of Chinese people. Kangyuan people have a common mission, follow the same values, and always adhere to the tenet of "helping the world and health, and making contributions to Hongyuan" to serve and repay the society. At present, the company's annual operating revenue is billions of yuan, and the annual tax payment is hundreds of millions of yuan. With the rapid development of the company and full confidence in the future development of China's economy and the global calcium preparation market, Beijing Zhendong Kangyuan Pharmaceutical Co., Ltd. is constantly accelerating innovation, strategizing and brewing a hundred year plan. In the future, Kangyuan will eventually become a world pharmaceutical company with excellent technology and equipment and well managed.

本文链接: https://www.waitui.com/brand/52bc17e3b.html 联系电话:01056940619

千城特选小程序码

7×24h 快讯

“不停科技”完成新一轮A++轮融资

36氪获悉,近日,数字厨房解决方案提供商“不停科技”完成新一轮A++轮融资,融资金额超千万美元。此轮融资由投资机构创世伙伴创投领投,星辰资本担任融资的长期独家财务顾问。这是不停科技继A+轮融资后半年内完成的又一笔融资。目前,不停科技的数字厨房已部署于24个国家和地区,涵盖餐饮、航空、酒店、企业餐饮等多元场景。

2小时前

中美已经或正在沟通关税问题?外交部:愿保持沟通,妥处分歧

外交部发言人毛宁主持例行记者会。外媒记者就关税问题提问,请问中美双方是否已经或正在就关税问题沟通?毛宁表示,“我可以告诉你的是,我们愿意同美方保持沟通,妥善处理分歧,拓展互利合作,推动中美关系稳定、健康、可持续的发展。”(澎湃)

2小时前

佳兆业集团等在深圳成立商务服务合伙企业,出资额24.8亿

36氪获悉,天眼查App显示,近日,深圳市福田佳之园商务服务合伙企业(有限合伙)成立,执行事务合伙人为佳兆业旅游科技(深圳)集团有限公司、深圳锦恒财富管理有限公司,出资额约24.8亿人民币,经营范围包括企业管理咨询、会议及展览服务、信息技术咨询服务等。合伙人信息显示,该企业由佳兆业集团、佳兆业正汉置业(深圳)有限公司、佳兆业城市更新集团(深圳)有限公司等共同出资。

2小时前

浙江2024年以旧换新带动消费超1700亿元

2024年浙江强力推进以旧换新,全省汽车以旧换新累计申请59.4万辆,家电以旧换新700余万台,带动消费超1700亿元。(新华社)

2小时前

春节打车需求将上涨25% 滴滴超4亿元补贴致敬司机保障春运

36氪获悉,滴滴出行数据显示,春运以来,前往机场、火车站的打车订单同比上涨16%,入境用户的滴滴打车订单涨超55%。春节期间,预计打车需求同比上涨25%,滴滴发放超4亿司机补贴、试行节假日司机服务费,致敬假期中辛勤出车的司机师傅们。

2小时前

本页详细列出关于MoveFree益节的品牌信息,含品牌所属公司介绍,MoveFree益节所处行业的品牌地位及优势。
咨询